Ralf Kuriyel is Senior VP, R&D of REPLIGEN CORP. Currently has a direct ownership of 12,288 shares of RGEN, which is worth approximately $1.71 Million. The most recent transaction as insider was on Aug 02, 2024, when has been sold 7,148 shares (Common Stock) at a price of $159.11 per share, resulting in proceeds of $1,137,318. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.3K
0% 3M change
47.83% 12M change
Total Value Held $1.71 Million

RALF KURIYEL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 02 2024
SELL
Open market or private sale
$1,137,318 $159.11 p/Share
7,148 Reduced 36.78%
12,288 Common Stock
Aug 02 2024
BUY
Exercise of conversion of derivative security
$15,067 $86.1 p/Share
175 Added 1.38%
12,463 Common Stock
Aug 01 2024
SELL
Open market or private sale
$739,716 $165.67 p/Share
4,465 Reduced 18.82%
19,261 Common Stock
May 14 2024
SELL
Payment of exercise price or tax liability
$87,223 $163.34 p/Share
534 Reduced 2.2%
23,726 Common Stock
Mar 11 2024
SELL
Open market or private sale
$681,348 $193.73 p/Share
3,517 Reduced 12.66%
24,260 Common Stock
Mar 11 2024
BUY
Exercise of conversion of derivative security
$109,433 $86.1 p/Share
1,271 Added 4.38%
27,777 Common Stock
Mar 07 2024
SELL
Payment of exercise price or tax liability
$75,547 $195.72 p/Share
386 Reduced 1.44%
26,506 Common Stock
Mar 04 2024
SELL
Payment of exercise price or tax liability
$26,188 $193.99 p/Share
135 Reduced 0.5%
26,892 Common Stock
Mar 01 2024
SELL
Payment of exercise price or tax liability
$86,880 $191.79 p/Share
453 Reduced 1.65%
27,027 Common Stock
Feb 29 2024
BUY
Grant, award, or other acquisition
-
404 Added 1.45%
27,480 Common Stock
Feb 27 2024
BUY
Grant, award, or other acquisition
-
3,520 Added 11.5%
27,076 Common Stock
May 16 2023
SELL
Payment of exercise price or tax liability
$109,361 $154.03 p/Share
710 Reduced 2.93%
23,556 Common Stock
Mar 03 2023
SELL
Payment of exercise price or tax liability
$234,436 $188.0 p/Share
1,247 Reduced 4.89%
24,266 Common Stock
Mar 03 2023
BUY
Grant, award, or other acquisition
-
3,591 Added 12.34%
25,513 Common Stock
Mar 02 2023
BUY
Grant, award, or other acquisition
-
3,468 Added 13.66%
21,922 Common Stock
Feb 28 2023
SELL
Payment of exercise price or tax liability
$62,034 $173.28 p/Share
358 Reduced 1.9%
18,454 Common Stock
Feb 28 2023
SELL
Payment of exercise price or tax liability
$79,435 $173.44 p/Share
458 Reduced 2.38%
18,812 Common Stock
Aug 11 2022
SELL
Open market or private sale
$1,232,603 $254.67 p/Share
4,840 Reduced 20.07%
19,270 Common Stock
Aug 11 2022
BUY
Exercise of conversion of derivative security
$238,240 $59.56 p/Share
4,000 Added 14.23%
24,110 Common Stock
May 13 2022
SELL
Payment of exercise price or tax liability
$107,085 $150.4 p/Share
712 Reduced 3.42%
20,110 Common Stock
Feb 28 2022
SELL
Payment of exercise price or tax liability
$404,612 $196.7 p/Share
2,057 Reduced 8.99%
20,822 Common Stock
Feb 28 2022
BUY
Grant, award, or other acquisition
-
4,234 Added 15.89%
22,406 Common Stock
Feb 27 2022
SELL
Payment of exercise price or tax liability
$93,826 $196.7 p/Share
477 Reduced 2.49%
18,645 Common Stock
Feb 24 2022
SELL
Payment of exercise price or tax liability
$35,571 $189.21 p/Share
188 Reduced 0.97%
19,122 Common Stock
Feb 24 2022
BUY
Grant, award, or other acquisition
-
2,126 Added 9.92%
19,310 Common Stock
RK

Ralf Kuriyel

Senior VP, R&D
Waltham, MA

Track Institutional and Insider Activities on RGEN

Follow REPLIGEN CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGEN shares.

Notify only if

Insider Trading

Get notified when an Repligen Corp insider buys or sells RGEN shares.

Notify only if

News

Receive news related to REPLIGEN CORP

Track Activities on RGEN